Jane Street’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
VCM
BTW
Jane Street's AMPH Position: Q1 2026 in Review
Jane Street reduced its Amphastar Pharmaceuticals (AMPH) stake by 57% in Q1 2026, selling an estimated $3.06M and leaving 92,475 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #5289.
Jane Street first reported a position in AMPH in Q4 2021 and has held it in 18 quarters since. The position peaked at $5.83M in Q4 2025. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- Jane Street held 92,475 shares of Amphastar Pharmaceuticals worth $1.81M as of Q1 2026.
- Jane Street sold 125,062 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $3.06M.
- Amphastar Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5289 holding.
- Jane Street first reported a position in Amphastar Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
- Jane Street's Amphastar Pharmaceuticals position peaked at $5.83M in Q4 2025.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.